ARKG vs DVY
ARK Genomic Revolution ETF vs iShares Select Dividend ETF
ARKG$47.17
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: 0.75%Yield: 0.00%
DVY$162.67
iShares Select Dividend ETF
100 high-dividend-yielding US stocks.
Expense: 0.38%Yield: 3.29%
Quick take
- • DVY has the lower expense ratio at 0.38% vs 0.75% for ARKG.
- • DVY pays a higher dividend yield (3.29%).
Side-by-side metrics
| Metric | ARKG | DVY |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.38% |
Dividend yield Trailing 12-month yield. | 0.00% | 3.29% |
AUM Assets under management — bigger funds are typically more liquid. | $2.21B | $23.69B |
YTD return | 66.55% | 17.74% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.11 | 0.51 |
P/E ratio | — | 14.69 |
Last price | $47.17 | $162.67 |
Inception | — | — |
Issuer | ARK | iShares |
ARKG top holdings
Top holdings · ARKG
| TWST | Twist Bioscience Corp | 8.75% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 8.73% |
| TEM | Tempus AI Inc Class A common stock | 8.36% |
| ABSI | Absci Corp | 5.56% |
| CRSP | CRISPR Therapeutics AG | 5.22% |
| GH | Guardant Health Inc | 4.88% |
| NTRA | Natera Inc | 4.71% |
| ILMN | Illumina Inc | 4.69% |
| LLY | Eli Lilly and Co | 3.92% |
| BEAM | Beam Therapeutics Inc | 3.69% |
Sector breakdown · ARKG
Healthcare100.0%
DVY top holdings
Top holdings · DVY
| PFE | Pfizer Inc | 2.46% |
| MO | Altria Group Inc | 2.38% |
| HPQ | HP Inc | 2.16% |
| PRU | Prudential Financial Inc | 2.12% |
| TROW | T. Rowe Price Group Inc | 1.99% |
| OKE | ONEOK Inc | 1.84% |
| TGT | Target Corp | 1.68% |
| VZ | Verizon Communications Inc | 1.66% |
| CVX | Chevron Corp | 1.62% |
| KMB | Kimberly-Clark Corp | 1.61% |
Sector breakdown · DVY
Consumer Cyclical9.8%
Basic Materials2.1%
Consumer Defensive13.9%
Technology3.1%
Communication Services5.3%
Financial Services24.8%
Utilities22.4%
Industrials1.9%
Energy11.0%
Healthcare5.7%
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About DVY
DVY (iShares Select Dividend ETF) is 100 high-dividend-yielding US stocks. Managed by iShares, the fund carries $23.7B in assets under management, an expense ratio of 0.38%, a dividend yield of 3.29%. Its largest holding is Pfizer Inc (PFE), which represents 2.5% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 9.8%.